From a technical standpoint, GLP-1 receptor agonists like Ozempic and Wegovy influence the release of insulin, slow gastric emptying, and modulate hunger signals, which in turn affect metabolic parameters
The Revita clinical profile in this study suggests we have the potential to create a new standard of care in obesity with a disease-modifying intervention that allows us to progress from chasing weight loss to sustaining health with a durable metabolic reset. Upcoming Milestones The REMAIN-1 Midpoint Cohort is ongoing, with 6-month data expected in Q1 2026
Not intended for pregnant or lactating women
The Rise of Melanotan on Social Media Unfortunately, social media is playing a significant role here, as Melanotan has seen a worrying surge in popularity on platforms like TikTok
If symptoms are particularly severe following a dose increase, discuss with your prescriber whether slowing the titration schedule might be appropriate